Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis

…, E Lianidou, AD Romaschin, RJ Honey, R Stewart… - Clinical …, 2010 - Elsevier
OBJECTIVE: We seek to identify the differentially expressed miRNAs in the clear cell subtype
(ccRCC) of kidney cancer. DESIGN AND METHODS: We performed a miRNA microarray …

miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation

…, E Fatoohi, M Metias, RJ Honey, R Stewart… - The Journal of …, 2011 - Elsevier
PURPOSE: Renal cell carcinoma is the most common neoplasm of the adult kidney.
Currently to our knowledge there are no biomarkers for diagnostic, prognostic or predictive …

The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma

…, S Metias, Y Rofael, RJ Honey, R Stewart… - The Journal of …, 2010 - Elsevier
PURPOSE: miRNAs are small, nonprotein coding RNAs that are differentially expressed in
many malignancies. We previously identified 80 miRNAs that are dysregulated in clear cell …

[HTML][HTML] Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma

…, S Metias, AD Romaschin, RJ Honey, R Stewart… - Oncotarget, 2014 - ncbi.nlm.nih.gov
There are no serum biomarkers for the accurate diagnosis of clear cell renal cell carcinoma (ccRCC).
Diagnosis and decision of nephrectomy rely on imaging which is not always …

Quantitative proteomic analysis in metastatic renal cell carcinoma reveals a unique set of proteins with potential prognostic significance

…, B Khalil, AD Romaschin, RJ Honey, R Stewart… - Molecular & Cellular …, 2013 - ASBMB
Metastatic renal cell carcinoma (RCC) is one of the most treatment-resistant malignancies,
and patients have a dismal prognosis, with a <10% five-year survival rate. The identification of …

A comparison of patient-controlled sedation using either remifentanil or remifentanil-propofol for shock wave lithotripsy

…, MT Kataoka, L Errett, K Pace, RJ Honey - Anesthesia & …, 2001 - journals.lww.com
Patient-controlled sedation (PCS) has been used for extracorporeal shock wave lithotripsy (SWL)
because it allows for rapid individualized titration of anesthetics. Because of its …

Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry

…, AD Romaschin, RJ Honey, R Stewart… - Journal of proteome …, 2009 - ACS Publications
Renal cell carcinoma (RCC) is the most common neoplasm in the adult kidney. Unfortunately,
there are currently no biomarkers for the diagnosis of RCC. In addition to early detection, …

Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses

…, H Antonios, TT Bao, MD Pasic, RJ Honey, R Stewart… - Tumor Biology, 2012 - Springer
Metastasis results in most of the cancer deaths in clear cell renal cell carcinoma (ccRCC).
MicroRNAs (miRNAs) regulate many important cell functions and play important roles in tumor …

Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs

…, Y Youssef, M Mankaruos, RJ Honey, R Stewart… - 2010 - degruyter.com
Renal cell carcinoma (RCC) accounts for 3% of all adult malignancies and currently no
diagnostic marker exists. Kallikrein-related peptidases (KLKs) have been implicated in numerous …

Aluminum toxicity and death following intravesical alum irrigation in a patient with renal impairment

…, CA Radzinski, NW Struthers, RJ Honey - The Journal of …, 1992 - Elsevier
Intravesical alum irrigation is the safest and most effective method of treatment for intractable
hematuria. Systemic absorption is reported to be minimal and there have been no reported …